AKTX

Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress

Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)

Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma

Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies

Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease

Akari Therapeutics to Participate in Two January Virtual Investor Conferences

Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress